Abstract
Following the initial report of Rosen in 1976 [1], a study of preoperative chemotherapy for treatment for primary osteosarcoma patients was started in our hospital in 1978.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Rosen G, Murphy ML, Huvos AG, et al. Chemotherapy, en bloc resection and prosthetic bone replacement in the treatment of osteogenic sarcoma. Cancer 37:1–11, 1976.
Rosen G, Caparros B, Huvos AG, et al. Preoperative chemotherapy for osteogenic sarcoma. Cancer 49:1221–1230, 1982.
Rosen G, Marcone RC, Caparros B, et al. Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgery. Cancer 43:2163–2177, 1979.
Ettinger LJ, Douglass HO, Higby DJ, et al. Adjuvant adriamycin (Adr) and cis-diammine dichloro-platinum (cis-platinum) in primary osteosarcoma. Cancer 47:248–254, 1981.
Enneking WF. Modified system for functional evaluation of surgical management of musculoskeletal tumors. In: Limb Salvage in Musculoskeletal Oncology. Enneking WF, Ed. Churchill Livingstone, New York, pp 626–639, 1987.
Veth RPH, Graaf SSN de, Heeten GH den, et al. Epiphyseal fractures in children, treated with chemotherapy, tumor resection and endoprosthesis. J Surg Oncol 26: 40–46, 1984.
Winkler K, Beron G, Delling G, et al. Neoadjuvant chemotherapy of osteosarcoma: result of a randomized cooperative trail (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 6:329–337, 1988.
Bacci G, Avella M, Capanna R, et al. Neoadjuvant chemotherapy in the treatment of osteosarcoma of the extremities: preliminary results in 131 cases treated preoperatively with methotrexate and cisdiammino platinum. Ital J Orthop Traum 14:23–29, 1988.
Prasad R, Bacci G, Campanacci M, Picci P. Does drug dose intensity (DDI) of chemotherapy (C) determine the prognosis of primary high grade osteosarcoma? Proc Am Soc Clin Oncol 9:311, (abstract 1202) 1990.
Miser J, Pritchard D, Sim F, et al. Treatment of osteosarcoma (OGS) with a new chemotherapeutic regimen of ifosfamide (Ifos), Adriamycin (ADR) and high dose methothrexate (HDMTX) (abstract 1143) Proc Am Soc Clin Oncol 9:295, 1990.
Rosen G. The current management of malignant bone tumors: where do we go from here? Med J Austr 148:373–377, 1988.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Postma, A., Kamps, W.A., Koops, H.S., Veth, R.P.H., Göeken, L.N.H., Molenaar, W.M. (1993). Osteosarcoma of the limb: An institutional report of 10 years experience with neoadjuvant chemotherapy and delayed surgery. In: Humphrey, G.B., Koops, H.S., Molenaar, W.M., Postma, A. (eds) Osteosarcoma in Adolescents and Young Adults: New Developments and Controversies. Cancer Treatment and Research, vol 62. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3518-8_45
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3518-8_45
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6561-7
Online ISBN: 978-1-4615-3518-8
eBook Packages: Springer Book Archive